Abstract
56: Phase 2 Trial of Neoadjuvant Metformin and Temozolomide Followed by Hypofractionated Accelerated Radiotherapy with Concomitant and Adjuvant Metformin and Temozolomide in Patients with Newly Diagnosed Glioblastom
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have